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examined the role ofAPC (monocytes and B ceils) in presentation 
of Asp to T ceils by comparing proliferative responses of APC- 
depleted and non-depleted samples. Mthough proliferation was 
greater in the presence of APe, depleted samples howed signifi- 
cant proliferation (SI 2-30) indicating that Asp directly stimulates 
T cell proliferation. These results how a moderately strong CD4 
and CD8 T cell response to Asp that shows some TCR V]3 
restriction. The T cell proliferative response to Asp appears to be 
partly mediated by a non-classical APC-independent pathway. 
These findings should facilitate the generation of Asp-specific T
ceils for adoptive immunotherapy. 
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THI AND TH2 CYTOKINE SYNTHESES BY T CELLS OF RECIPIENTS OF 
G-CSF MOBILIZED ALLOGENEIC PBSC 
Lee, B.; KovbliJ~g, M.; Gao, H.; S/:e~7, D.; Ma:'tiJze~, 3:1.3/1.; 
C,bamplin, R.; Re~lbe~z, ff.M. M.D.A1zde'~'soH CaT~cer CeJztet', Hoz/s- 
to~, TJC 
Transplantation f G-CSF-mobilized PBSC is associated with 
less acute GVtlD (aGVHD) and improving engraftment despite 
much larger numbers of T ceils in unmanipulated PBSC prepara- 
tions than in bone marrow grafts. As urvival of the graft is depend- 
ent on the Thl /Th2 cytokine balance, we measured the syntheses 
of Th l  (IL-2, TNF-alpha, and IFN-gamma) and Th2 (IL-10) 
cytokines by CD4+ and CDS+ T ceils in vitro following activation 
with phorbol ester (PMA) and Staphylococcus enterotoxin B (SEB) 
at 2, 4, 6, and 8 weeks, post-transplantation andanalyzed the cells 
syuthesizing cytokines by 4-color flow cytomett T. Typically, the 
number of CDS+ T cells that synthesized TNF-alpha, IFN- 
gamma, and IL-2 following activation with PMA and SEB steadily 
increased with engraftment. The number of CD4+ T ceils that 
were activated with PMA also steadily increased with engraftment; 
however, the number of SEB-activated CD4+ T ceils that synthe- 
sized IL-2 peaked at 4 weeks, post-transplantation and declined 
thereafter. By comparison, the number of CD4+ and CD8+ T cells 
that syuthesized IL-10 in response to activation by PMA and SEB 
peaked at 4 weeks and declined precipitously by week 8, post-trans- 
plantation. Since only one patient developed GVHD that resolved 
during the monitoring period, the increased syntheses of Th l  
cytoldnes by activated CD4+ and CD8+ T cells after engraftment 
and at a time when G-CSF maintenance was no longer provided is 
indicative of the immune competence of the engrafted cells and 
their propensity for producing Thl  cytokines upon activation, an 
event hat could potentially lead to the development of GVI ID. 
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RAPID RECONSTITUTION OF SERUM ANTI-PRP ANTIBODY LEVELS IN 
RECIPIENTS OF ALLOGENEIC MARROW TRANSPLANTATION 
Bolotizz, E.; Reiss, U.; I4,~lltevs, M. Chihh'em" Hospital aTzd Research 
CeJm, r at Oak~an& OaklaJld, CA. 
As immediate survival of the transplant recipients improves, pre- 
vention of early and Iate post-transplant infectious c mplications 
plays a major role in long-term outcome. Timely re-immunization 
for pediatric stem cell transplant (HSCT) recipients may prevent 
devastating complications of vaccine-preventable diseases. 
Immune responses to polysaccharide vaccines (H. influcnzae type 
b, pneumococcal nd meningococcal) have been suboptimal early 
post-transplant. Polyribosyl-ribitol phosphate (PRP) is an essen- 
tial componcnt of bacterial capsular polysaccharides, such as of 
Streptococcus pneumoniae or Hemophilus influenzae. Natural 
antibodies to the polysaccharides develop as a result of the anti- 
genic crossreactivity with E.coli strains. To evaluate the time and 
pattern of anti-PRP titers in pediatric patients after allogeneic 
related HSCT 7 patients were evaluated 6-12 months post- BMT. 
Two patients had a history of acute graft versus host disease, how- 
ever all patients were off immunosuppression at the time of evalu- 
ation. Titers were measured by enzyme-linked immunosorbent 
assay (ELISA) at Children's Hospital Los Angeles; CA. Serum 
anti-PRP titers varied from 16 to 900 pg/ml, median 117pg/ml. 
Anti-PRP titers were higher (200-900 pg/ml, mean 900 pg/ml) in 
patients with non-malignant diseases compared to patients with 
malignancies (16-228, mean 48 pg/ml). There were no significant 
correlation with the T and B ceil counts and T cell function. Non- 
protective anti-PRP levels (less than i00 pg/ml) at 1 year after 
I tSCT were observed in two AML patients. In one low anti-PRP 
titers were associated with non-detectable anti-tetanus, anti-diph- 
theria antibody titers and low B cell count. In this study we 
observe rapid reconstitution of the serum anti-PRP titers in 5 of 7 
recipients of allogeneic BMT. Currently we are studying the pre- 
dictability of serum anti-PRP ievels with regard to functional 
responses to vaccination post-BMT. 
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ANTI-CD3 STIMULATED T REGULATORY CELLS DO NOT INHIBIT 
SYNGENEIC BONE MARROW PROGENITOR CELL PROLIFERATION 
Dayao, Z.RS; Marl's, L.:; Levy, R. 2 l. Divisio*z of Hematology~ 07zcol- 
og)', Sylvestev Cmzcev Ce*~te~'- U, ziversity of k/liami, Mia71~i, FL; 
2. Uniz,elsi U of dVIiuTni School of Me,ticil~e, Miami, FL. 
CD4+CD25 * T (T reg) cells with regulatory function are being 
considered for use to control GVHD and support successful allo- 
geneic bone marrow transplantation. T reg cells are present in the 
spleen and bone marrow and have been reported to produce 
cytokines including TGF]3. Since encounter with antigen post 
BMT can activate Treg populations, the presence of such ceils in 
recipient lymphohelnatopoietic conapartments raises the possibili- 
ty that TGF{3 or other cytokines could affect progenitor cell activ- 
ity. Low density (LD) B6 bone marrow cells (Sxl03/well) were 
supplemented with rmIL3 to induce proliferative responses in 72 
hour cultures. Highly enriched Treg populations were then pro- 
duced fi'om spleen and lymph nodes of B6 (H-219 mice. When 
added to cultures containing purified syngeneic CD4+CD25 - T 
cells (SxlOVwell), syngeneic accessory cells (Sxl0~/well) and anti- 
CD3 nLAb (15%), the Treg cells (1:1) effectively inhibited (>70%) 
the proliferative response by the CD4+CD25- responding cells. To 
examine the ability, of T reg cells to regnlate BMC proliferation, 
CD4+CD25 + T ceils were cultured with LD BMC and syngeneic 
accessory cells in the presence of anti-CD3 nzAb. At high (10:1) 
Treg : LD BMC numbers, the BMC proliferative responses were 
not inhibited. In summary, the present i71 vitro findings support 
the notion that activation of CD4+CD25 + T reg cells during BMT 
will not interfere with t e proliferative activity of transplanted or
host progenitor populations. Interestingly, when both 
CD4+CD25 T cells and LD BMC were cultured together with 
Treg cells in the presence of IL-3 and anti-CD3, strong prolifera- 
tive responses were detected in these cultures. These findings raise 
the possibility that CD4*CD25 + regulatory cells do not inhibit 
proliferative responses in the presence of IL3 and BMC. Experi- 
ments are currently examining if T reg ceils fail to suppress the 
response of the CD4+CD25 T cells in these cultures. 
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SEX STEROID ABLATION BY CASTRATION ENHANCES HAEMOPOI- 
ETIC RECOVERY FOLLOWING ALLOGENEIC BONE MARROW 
TRANSPLANTATION 
Goldl, erg, G.L.I; Alpcloga1~, 0.:; Mu~'iglm~, S.J.:; 14,7i/lis, L.M.:; 
G*'eeizbeJ'g, A.S.~-; Bwd, R.L2; va~ cle71 Bri71k, M.R. 2 1. Pathology mzd 
I~zTn#~zologv, Mol~asb UMveT"sity, Melboz~twe, VIC, Aztst¢-alia; 
2. 3/le'/Jzo~ial Sloml Ketterhg CaT~ce*" Ce,zter', New Yo*'/e, NI£ 
"['here is a general decline in immune function with age. This 
process, which involves thymic atrophy, is known to be reversed 
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by sex steroid ablation which also increases bone marrow (BM) 
and peripheral B cell nmnbers. Innnune reconstitution is severely 
retarded in adult recipients of an allogeneic BMT. These experi- 
ments aimed to establish whether sex steroid ablation influenced 
haemopoietic recovery following allogeneic bone marrow trans- 
plantation. One day prior to allogeneic BMT, mice were surgical- 
ly castrated. 14 days after BMT, bone marrow (16x106_+l.4x106) 
and thymic (55.4x106_+l.Sx106) cell nmnbers were significantly 
increased in the castrated mice compared to sham controls 
(9.5x106_+3.0x10 ~ and 25x10~--2.6x10% These remained elevated at 
day 28 (BM: 22x106-+4.0x106 vs. 14x10~'--2.2x106; thymus: 
72x106+5.gx10 ~ vs. 45x10a--2.9x106) at whicln time splenic cellular- 
ity was also increased in the castrates. Thymocyte subsets were 
increased I4 and 28 days after BMT and castration. Thymic den- 
dritic cell numbers were also increased in castrated mice 28 days 
following BMT suggesting a possible role in graft acceptance. BM 
precursors and developing B cells were significantly increased 28 
days after BMT and castration. These central increases translated 
to a significant increase in donor-derived peripheral T and B ceils 
28 days after allogeneic BMT. Every immune-enhancing strategy 
carries the risk of exacerbating the development of graft-versus- 
host disease (GVHD). Mice were castrated at the same time as 
GVHD induction in an allogeneic setting. There was no signifi- 
cant difference in GVHD incidence or severity when comparing 
castrated and sham-castrated mice. We have previously shown 
that lymphoid recovery is enhanced in allo-BMT recipients after 
IL-7 treatment. The combination of IL-7 treatment and castra- 
tion appeared to have an additive effect in the thynms 28 days 
after allogeneic BMT. These results indicate that castration and 
the resulting ablation of sex steroids enhance haemopoietic recov- 
ery following allogeneic BMT without increasing GVHD. 
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DONOR LYMPHOCYTE INFUSION (DLI) FROM A HLA IDENTICAL SIB- 
LING TO TREAT A COMPLETE DIGEORGE ANOMALY (CDGA) 
Cellot, S.I; Bllsqz~e, £.e; Dural, M. l; ~'Uagne~', E. 1, Lapointe, N.I; 
Dalle, J.~; a/ati0/i, y.:; Cha~Hpagne, 3~i. ~ I. H@ital Ste-Jus#ne, 3/l~m- 
treal, QC, Cm~ada; 2. H@iml M, Ssmmez~ve-Rosemont, M real, QC, 
Cm~ada. 
OBJECTIVE cDGA is characterized by a profound T-cell 
immune deficiency, thymic aplasia, hypoparathyroidism, con- 
genital cardiopathy and facial dysmorphism. Therapeut ic  
attempts for this condition include thymic transplant and relat- 
ed BMT, with variable outcomes. DLI allows selective T-cel] 
reconstitution i these rare patients, eliminating the need for a 
complete BMT procedure. However, studies on donor/recipi- 
ent chimerism in the various myeloid and lymphoid fractions in 
these patients are limited. We have followed the evolution of 
molecular chimerism in these cell populations, and of the T 
cell repertoire diversity, in a cDGA patient reated by DLI (4x 
106CD3+ cells/kg), without stem-cell mobilization, condition- 
ing regimen, nor GVH prophy]axis. METHOD Molecular 
chimerism analysis was done by PCR amplification of repetitive 
DNA sequences (STR) at 2 loci enabling distinction between 
donor and recipient. Chimerism was determined at the level of 
the CD3+, CD4+, CD8+, CD19+ and CD56+ populations, 
obtained by flow cytometric ell sorting. Peripheral blood 
polymorphonuclear cells were used for myeloid lineage 
chimerism analysis. T-cell repertoire diversity and clonality 
was estimated by studying T-cell  receptor gamma chain 
rearrangements within the CD3+ cell population. RESULTS 
hmnune reconstitut ion is 100% dbnor at the T-cel l  level 
(CD3+, CD4+ and CDS+) and practically absent in other line- 
ages. A net increase in donor-derived chimerism was observed 
in granulocytes following acute hepatic and medullary (pancy- 
topenia) GVH, treated with corticosteroids and cyclosporine. 
T ceil repertoire clonal diversity in relation to clinical events 
will be presented. CONCLUSION DL1 allows rapid donor 
derived T-cel l  iminunc reconstitution, protection against 
opportunistic infections despite absence of thymus, and a low 
level of donor granulopoiesis n this patient (up to 12 nmnths 
of follow-up). 
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LYMPHOCYTE RECOVERY AFTER ALLOGENEIC STEM CELL TRANS- 
PLANTATION: COMPARISON OF BONE MARROW AND PERIPHERAL 
BLOOD STEM CELL TRANSPLANTATION 
Kumav, S.; 3/licall@ I.N.; Porvatta, L.F., Elliot, ~VI.A.; Arise/l, 
S.M.; Dispel~zieri, A.; Lacy, M.Q.; Inwards, D.J.; Teffe'ri, A.; 
Gastinealt, D.A.; Gertz, M.A.; Litzow, M.R. Mayo Clillic, 
RochesteJ; M)~ 
Background: Rate of lymphocyte recovery after allogeneic 
bone marrow transplantation has been demonstrated to be 
strong predictor of post ransplant relapse in patients with acute 
myelogenous leukemia and acute lymphoblastic leukemia. 
Peripheral blood as a source of stem cells is gradually replacing 
bone marrow for allogeneic transplants as it has already done 
for autologous tem cell transplantation. It is not clear if the 
kinetics of the lymphocyte recove W after PBSCT is comparable 
to that seen with BMT. Methods and Materials: We identi- 
fied 32 adult patients who had undergone allogeneic PBSCT 
for various hematological malignancies at Mayo Clinic, 
Rochester between I984 and 200I. Sixty-four patients who 
underwent allogeneic BMT who were matched for diagnosis, 
conditioning regimen, GVHD prophylaxis, HLA match and age 
for comparison. The absolute lymphocyte count (ALC) meas- 
ured at day 21 and 30 post transplant were obtained from the 
medical records. Results: We did not find any difference in the 
rate of lymphocyte recovery following allogeneic stem cell 
transplant with the use of BM or PBSC as the source of stem 
ceils. The median M~C on day 21 for the PBSCT group was 
170 (range 0-800) and for the BMT group was 175 (range 0- 
1090); P = 0.I. For day 30, the median ALC was 365 (range 20- 
930) for the PBSCT group and 410 (range 40-1760) for the 
BMT group respectively, P - 0.1. Discussion: Use of peripher- 
al blood stem cells has been associated with a faster hematopoi- 
etic engraftment compared to BM as the source of stem cells. 
In this study we have demonstrated that the lymphocyte recov- 
ery remains unchanged irrespective of the source of the stem 
cells. Therefore, it is likely that the previously published results 
on the prognostic value of lymphocyte recovery following BMT 
can be extrapolated to the setting of PBSCT with similar cutoff 
values. 
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EBV-ASSOCIATED LYMPHOPROLIFERATIVE DISORDER DEVELOPING 
AFTER CONDITIONING WITH RABBIT ATG 
Peres, E.3/I.; Madgie, A.; Abel/a, E.: Dansev, R. Stem cell Transplant, 
I'2a~w~anos Cancer bzstitHte, Detroit, 3/11. 
Post bone marrow transplant Epstein-Barr virus (EBV) associ- 
ated Lyphoproliferative disorder (LPD) can be fatal in the 
ilnmuncompronfized host. The major risk factor for the develop- 
ment of EBV-LPD is ex-vivo T cell depletion, and the in-vivo 
T-cell depletion steps caused by ATG and monoclonal T cell 
antibodies. Between March 1999 and Janual T 2001 a total of 539 
patients received allogeneic and autologus bone marrow trans- 
plants at the karmanos cancer institute. During that same time 
period 3 patients median age 21 (range 1-35) received rabbit 
ATG as part of their conditioning regimen and developed EBV- 
LPD. Occurring at a median of 70 days after bone marrow trans- 
plant (range 60-90) median dose of rabbit ATG was 
5mg/kg/dose (range 2.5-10). Treatment given in the 3 cases con- 
sisted of tapering immunosuppresion a d antiviral therapy, 
donor lymphocyte infusion in one case and chemotherapy in one 
case. We obselwcd a close association with the use of rabbit ATG 
and the development of EBV-LPD. We believe that close nmni- 
toring and periodic testing for EBV when using this agent should 
be considered when ATG is used as a part of the transplant con- 
ditioning regimen. 
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